207 reports of this reaction
10.1% of all CARBOPROST TROMETHAMINE reports
#1 most reported adverse reaction
VOMITING is the #1 most commonly reported adverse reaction for CARBOPROST TROMETHAMINE, manufactured by Pharmacia & Upjohn Company LLC. There are 207 FDA adverse event reports linking CARBOPROST TROMETHAMINE to VOMITING. This represents approximately 10.1% of all 2,057 adverse event reports for this drug.
Patients taking CARBOPROST TROMETHAMINE who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VOMITING is a frequently reported adverse event for CARBOPROST TROMETHAMINE, accounting for a significant proportion of all reports.
In addition to vomiting, the following adverse reactions have been reported for CARBOPROST TROMETHAMINE:
The following drugs have also been linked to vomiting in FDA adverse event reports:
VOMITING has been reported as an adverse event in 207 FDA reports for CARBOPROST TROMETHAMINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
VOMITING accounts for approximately 10.1% of all adverse event reports for CARBOPROST TROMETHAMINE, making it one of the most commonly reported side effect.
If you experience vomiting while taking CARBOPROST TROMETHAMINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.